These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11200420)

  • 1. Immunosuppression in liver transplantation.
    Cattral MS; Lilly LB; Levy GA
    Semin Liver Dis; 2000; 20(4):523-31. PubMed ID: 11200420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression in liver transplantation.
    Post DJ; Douglas DD; Mulligan DC
    Liver Transpl; 2005 Nov; 11(11):1307-14. PubMed ID: 16237688
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
    Cramer DV; Chapman FA; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future directions in immunosuppression.
    Beckebaum S; Cicinnati VR; Broelsch CE
    Transplant Proc; 2004 Mar; 36(2 Suppl):574S-576S. PubMed ID: 15041408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
    Faust TW
    Semin Liver Dis; 2000; 20(4):481-95. PubMed ID: 11200417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation?
    Beaudreuil S; Samuel D; Rouas-Freiss N; Durrbach A
    Transpl Immunol; 2007 Feb; 17(2):98-107. PubMed ID: 17306740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional and novel approaches to immunosuppression.
    Floreth T; Bhorade SM; Ahya VN
    Clin Chest Med; 2011 Jun; 32(2):265-77. PubMed ID: 21511089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for minimizing immunosuppression in kidney transplantation.
    Kirk AD; Mannon RB; Swanson SJ; Hale DA
    Transpl Int; 2005 Jan; 18(1):2-14. PubMed ID: 15612977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term immunosuppression and drug interactions.
    Levy GA
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S53-9. PubMed ID: 11689777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antilymphocyte induction therapy in liver transplantation.
    Wall WJ
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S64-70. PubMed ID: 10431019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of immunosuppression on growth and development.
    Balistreri WF; Bucuvalas JC; Ryckman FC
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):64-73. PubMed ID: 9346602
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing perspectives on the role of corticosteroids after liver transplantation.
    Lucey MR
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S58-63. PubMed ID: 10431018
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoral/cyclosporine-based immunosuppression.
    Levy GA
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S37-47. PubMed ID: 10431016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus for solid organ transplantation in children.
    Gupta P; Kaufman S; Fishbein TM
    Pediatr Transplant; 2005 Jun; 9(3):269-76. PubMed ID: 15910380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplant immunopharmacology: you can fool with mother nature!
    Vasquez EM; Westin ED
    Nurs Case Manag; 1999; 4(1):37-48. PubMed ID: 10232222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive agents in pediatric renal transplantation].
    Ismaili K; Abramowicz D; Adams B; Godefroid N; Lolin K; Schurmans T; Hall M; Janssen F
    Rev Med Brux; 2005; 26(6):505-12. PubMed ID: 16454154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunosuppressive pipeline: meeting unmet needs in liver transplantation.
    Selzner N; Grant DR; Shalev I; Levy GA
    Liver Transpl; 2010 Dec; 16(12):1359-72. PubMed ID: 21117245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of living-related liver transplantation.
    Hayashi M; Cao S; Concepcion W; Monge H; Ojogho O; So S; Esquivel CO
    Pediatr Transplant; 1998 Feb; 2(1):16-25. PubMed ID: 10084755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression, cancer, and the long-term outcomes after liver transplantation: can we do better?
    Abraham JM; Thompson JA
    Liver Transpl; 2010 Jul; 16(7):809-11. PubMed ID: 20583078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.